Caffeine and incidence of dyspnea in patients treated with ticagrelor

This publication has 10 references indexed in Scilit:

• Dyspnea in patients treated with P2Y₁₂ receptor antagonists: insights from the GReek AntiPlatElet (GRAPE) registry
  Platelets, 2017
• Design and rationale of TROCADERO: A TRial Of Caffeine to Alleviate DyspnEa Related to ticagrelOr
  American Heart Journal, 2015
• Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction
  New England Journal of Medicine, 2015
• Ticagrelor Increases Adenosine Plasma Concentration in Patients With an Acute Coronary Syndrome
  JACC, 2014
• Characterization of the Adenosine Pharmacology of Ticagrelor Reveals Therapeutically Relevant Inhibition of Equilibrative Nucleoside Transporter 1
  Journal of Cardiovascular Pharmacology and Therapeutics, 2014
• Differential Effect of Ticagrelor Versus Prasugrel on Coronary Blood Flow Velocity in Patients With Non–ST-Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
  Circulation: Cardiovascular Interventions, 2013
• Ticagrelor Enhances Adenosine-Induced Coronary Vasodilatory Responses in Humans
  JACC, 2013
• Characterization of dyspnoea in PLATO study patients treated with ticagrelor or clopidogrel and its association with clinical outcomes
  European Heart Journal, 2011
• Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
  New England Journal of Medicine, 2009
• Effects of Tezosentan on Symptoms and Clinical Outcomes in Patients With Acute Heart Failure
  JAMA, 2007